Cargando…
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
During treatment with fingolimod, B cells are redistributed from blood to secondary lymphoid organs, where they are protected from the effect of anti-CD20 and other cell-depleting therapies. We describe a multiple sclerosis patient who had almost complete depletion of B cells in blood during and sho...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077610/ https://www.ncbi.nlm.nih.gov/pubmed/30112230 http://dx.doi.org/10.1155/2018/5190794 |